© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Clinician and payer insight regarding complexities managing patients with chronic kidney disease and type 2 diabetes, and best practices utilizing newer treatment options.
September 30th 2021
Drs Rajiv Agarwal and Eugene Wright Jr. highlight risk factors associated with chronic kidney disease and react to concerns surrounding the assessment and treatment of patients.
Diagnostic criteria and special considerations of nephrologists when assessing patient kidney function and diagnosing chronic kidney disease.
October 7th 2021
Strategies to help clinicians talk with patients about chronic kidney disease staging and what to expect in terms of prognosis.
Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community.
October 14th 2021
A panel of clinicians explain why action is needed to help prevent the risk of progression of chronic kidney disease.
Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression.
October 21st 2021
Various types of health care professionals who may play a role in treating patients with chronic kidney disease, and recommendations to help overcome barriers that impact risk of disease progression and outcomes for patients.
Key takeaways from the National Kidney Foundation’s new HEDIS and MIPS quality measures for patients with chronic kidney disease and type 2 diabetes.
October 28th 2021
What better testing strategies and newer quality measures can do to improve patient referrals to nephrologists for earlier intervention of chronic kidney disease.
Considerations for establishing balance for the care of patients with chronic kidney disease among all types of care settings.